You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bms-986253

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • decitabine and cedazuridine
  • BMS-986253
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

Recruiting
  • Colon Carcinoma
  • Amsterdam, Netherlands
  • +5 more
Jan 23, 2023

NSCLC, Hepatocellular Carcinoma Trial in New York (Nivolumab, BMS-813160, BMS-986253)

Recruiting
  • Non-small Cell Lung Cancer
  • Hepatocellular Carcinoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 14, 2021

Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)

Terminated
  • Solid Tumor
  • +2 more
  • BMS-986253
  • New York, New York
    Columbia University Irving Medical Center
Nov 18, 2021

Cancer, Melanoma Trial in Worldwide (drug, biological, other)

Recruiting
  • Cancer
  • Melanoma
  • BMS-986253
  • +3 more
  • Springdale, Arkansas
  • +70 more
May 16, 2022